^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
CANCER:

CNS Tumor

Related cancers:
1d
Glioblastoma Multiforme: Current Developments in Molecular Pathways, Magnetic Field-Based Interventions, and Personalized Therapy. (PubMed, J Clin Pract Res)
Furthermore, static magnetic fields have been reported to increase apoptosis, inhibit proliferation, and may offer a complementary treatment with low toxicity. These findings suggest that magnetic-field-based approaches offer an innovative strategy for GBM treatment.
Review • Journal • PD(L)-1 Biomarker • IO biomarker
|
EGFR (Epidermal growth factor receptor) • TP53 (Tumor protein P53) • PTEN (Phosphatase and tensin homolog) • MGMT (6-O-methylguanine-DNA methyltransferase)
|
TP53 mutation • PTEN mutation • MGMT promoter methylation
1d
Intracholecystic Tubular Nonmucinous Neoplasm of the Gallbladder. (PubMed, Arch Pathol Lab Med)
The presence of morules, which display nuclear β-catenin expression, places this lesion in the so-called BROCN family of tumors, which are believed to be hormonally driven. Further molecular studies are needed to explore the roots of their behavior.
Review • Journal
|
CTNNB1 (Catenin (cadherin-associated protein), beta 1) • MUC6 (Mucin 6)
1d
Surgical Resection of Metastatic Male Breast Cancer to the Brain: An Illustrative Case Report. (PubMed, Clin Case Rep)
Postoperatively, he received adjuvant stereotactic radiosurgery (30-35 Gy in five fractions) to the resection cavity and was transitioned from tamoxifen to trastuzumab deruxtecan (T-DXd) for improved CNS-directed systemic therapy. Surveillance imaging at 6 months demonstrated no intracranial recurrence, and systemic restaging showed no extracranial disease progression. This case highlights the importance of prompt neuroimaging for new neurological symptoms in male breast cancer patients and supports a multimodal strategy, including surgical resection, focal radiation, and CNS-penetrant HER2-targeted therapy, for achieving durable intracranial control in select patients with isolated brain metastasis.
Journal
|
ER (Estrogen receptor) • PGR (Progesterone receptor)
|
HER-2 positive • ER positive • PGR positive
|
tamoxifen • Enhertu (fam-trastuzumab deruxtecan-nxki)
1d
CLIP2::MET fusion identifies a molecularly distinct glioneuronal tumor. (PubMed, Discov Oncol)
MET fusions are actionable oncogenic drivers across several cancers, and their detection has therapeutic relevance with approved inhibitors. This case expands the spectrum of MET-driven CNS tumors and suggests that CLIP2::MET fusion may represent a distinct molecular subset of glioneuronal tumors relevant to precision oncology.
Journal
|
BRAF (B-raf proto-oncogene) • IDH1 (Isocitrate dehydrogenase (NADP(+)) 1) • IDH2 (Isocitrate Dehydrogenase (NADP(+)) 2)
|
BRAF mutation
1d
Enrollment change
|
MGMT (6-O-methylguanine-DNA methyltransferase)
|
dasatinib • temozolomide
3d
Synthesis and Biological Evaluation of Novel Flavone-Sulfonamide Hybrid Derivatives as Potential Anticancer Agents. (PubMed, Curr Med Chem)
In summary, twelve novel flavone-sulfonamide hybrids were successfully synthesized and characterized. Biological evaluation identified compound 7f as the most active derivative against the NCI-60 panel, exhibiting broad-spectrum anticancer activity with low cytotoxicity. Molecular docking and ADME analyses further supported its potential, identifying compound 7f as a promising lead compound for further optimization. Incorporation of a sulfonamide group at the 6-position of the flavone scaffold resulted in an eightfold increase in anticancer activity (GI), from 7% for the flavone to 55% for lead compound 7f.
Journal
|
PARP1 (Poly(ADP-Ribose) Polymerase 1)
3d
Genetic variants in IGF2BP family genes are associated with glioma risk in Chinese children. (PubMed, Mol Med)
Genetic polymorphisms within IGF2BP family genes significantly modulate pediatric glioma susceptibility and have cumulative, subtype-specific, and age-dependent effects; thus, these genes may serve as promising noninvasive biomarkers for early risk stratification of childhood glioma.
Journal
|
IGF2BP1 (Insulin Like Growth Factor 2 MRNA Binding Protein 1) • IGF2BP2 (Insulin Like Growth Factor 2 MRNA Binding Protein 2) • IGF2BP3 (Insulin Like Growth Factor 2 MRNA Binding Protein 3)
3d
A Study of Avutometinib for People With Solid Tumor Cancers (clinicaltrials.gov)
P1, N=3, Active, not recruiting, Memorial Sloan Kettering Cancer Center | Recruiting --> Active, not recruiting | N=23 --> 3
Enrollment closed • Enrollment change
|
KRAS (KRAS proto-oncogene GTPase) • NRAS (Neuroblastoma RAS viral oncogene homolog) • HRAS (Harvey rat sarcoma viral oncogene homolog) • NF1 (Neurofibromin 1) • PTPN11 (Protein Tyrosine Phosphatase Non-Receptor Type 11)
|
Avmapki (avutometinib) • Fakzynja (defactinib)
3d
Recurrent IDH-mutant astrocytoma WHO grade 4 diagnosed during pregnancy: case report with literature review. (PubMed, Front Oncol)
Timely neurosurgical intervention, multidisciplinary care, and integrated obstetric-neurosurgical strategies are crucial. There is a pressing need for clinical guidelines addressing high-grade glioma management in pregnancy, particularly in the era of molecular tumor classification.
Journal
|
IDH1 (Isocitrate dehydrogenase (NADP(+)) 1) • CDKN2A (Cyclin Dependent Kinase Inhibitor 2A) • CDKN2B (Cyclin Dependent Kinase Inhibitor 2B)
|
IDH1 mutation • CDKN2A deletion
4d
Diffuse large B-cell lymphoma presenting as a scalp tumor with skull destruction and neurological symptoms: a case report. (PubMed, Front Immunol)
The patient was treated with Pola-R-CHP followed by CNS-directed therapy, including high-dose methotrexate and intrathecal chemotherapy...Tumor-associated RANKL expression may be associated with the osteolytic features observed in this case. Early biopsy and systemic evaluation of cutaneous lesions are essential, as they may reflect aggressive systemic disease.
Journal
|
TNFSF11 (TNF Superfamily Member 11)
|
Polivy (polatuzumab vedotin-piiq) • methotrexate IV
4d
Case Report: [225Ac]Ac-PSMA-617 therapy in a patient with metastatic castration-resistant prostate cancer (mCRPC) and intracranial meningioma. (PubMed, Front Oncol)
The hematological parameters remained stable for the whole period of observation. The presented clinical case report describes a unique positive experience on the use of [225Ac]Ac-PSMA-617 therapy in mCRPC and brain meningioma, thus allowing us to expand our understanding of PSMA RLT as a method for the treatment of not only prostatic tumors but also tumors of non-prostatic locations.
Journal
|
FOLH1 (Folate hydrolase 1)
|
FOLH1 expression
4d
Role of breast cancer resistance protein in pharmacokinetics of intrathecally administered methotrexate in mice. (PubMed, J Pharm Pharmacol)
BCRP may play an important role in MTX pharmacokinetics after intrathecal, but not intravenous, administration by regulating the CSF-to-blood transition in the CP and protecting against MTX-induced neurotoxicity.
PK/PD data • Preclinical • Journal
|
CRP (C-reactive protein)